This topic contains a solution. Click here to go to the answer

Author Question: Some people with borderline personality disorder can experience transient psychotic episodes. ... (Read 17 times)

jazziefee

  • Hero Member
  • *****
  • Posts: 505
Some people with borderline personality disorder can experience transient psychotic episodes.
 
  Indicate whether the statement is true or false

Question 2

The term subthreshhold syndrome in a categorical approach to diagnosis implies that the
 
  A) symptoms are too weak to be identified.
   B) client does not have enough of the symptoms to warrant a specific diagnosis.
   C) client is trying not to display symptoms of a specific disorder.
   D) model is not sensitive enough to detect pathology more than half of the time.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Beatricemm

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

TRUE

Answer to Question 2

B




jazziefee

  • Member
  • Posts: 505
Reply 2 on: Jun 22, 2018
Wow, this really help


bitingbit

  • Member
  • Posts: 323
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

People with high total cholesterol have about two times the risk for heart disease as people with ideal levels.

Did you know?

Nearly 31 million adults in America have a total cholesterol level that is more than 240 mg per dL.

Did you know?

Patients who cannot swallow may receive nutrition via a parenteral route—usually, a catheter is inserted through the chest into a large vein going into the heart.

Did you know?

There are major differences in the metabolism of morphine and the illegal drug heroin. Morphine mostly produces its CNS effects through m-receptors, and at k- and d-receptors. Heroin has a slight affinity for opiate receptors. Most of its actions are due to metabolism to active metabolites (6-acetylmorphine, morphine, and morphine-6-glucuronide).

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library